Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Endocrine
|
June 24, 2020
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?
Tommaso Porcelli, Domenico Salvatore
The Lancet. Diabetes & Endocrinology
|
March 3, 2022
The relevance of T<sub>3</sub> in the management of hypothyroidism
Domenico Salvatore, Tommaso Porcelli, Matthew D Ettleson, et al.
Frontiers in Endocrinology
|
June 6, 2018
Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report
Tommaso Porcelli, Francesca Sessa, Angela Caputo, et al.
Endocrine-Related Cancer
|
March 2, 2023
Deiodinases in thyroid tumorigenesis
Maria Angela De Stefano, Tommaso Porcelli, Martin Schlumberger, et al.
Future Oncology (London, England)
|
August 15, 2019
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib
Tommaso Porcelli, Francesca Sessa, Carla Gambale, et al.
The Lancet. Diabetes & Endocrinology
|
July 17, 2025
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism
Tommaso Porcelli, Maria Angela De Stefano, Cristina Luongo, et al.
Metabolites
|
November 25, 2021
Thyroid Hormone Action in Muscle Atrophy
Maria Angela De Stefano, Raffaele Ambrosio, Tommaso Porcelli, et al.
Endocrine-Related Cancer
|
May 1, 2025
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, et al.
Endocrine-Related Cancer
|
March 6, 2023
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence
Maria Angela De Stefano, Tommaso Porcelli, Raffaele Ambrosio, et al.
Journal of Occupational and Environmental Medicine
|
June 22, 2022
The Impact of Thyroid Diseases on Patients' Work Functioning: A Pilot Study
Ilaria Vetrani, Veruscka Leso, Luca Fontana, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Endocrine
|
June 24, 2020
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?
Tommaso Porcelli, Domenico Salvatore
The Lancet. Diabetes & Endocrinology
|
March 3, 2022
The relevance of T<sub>3</sub> in the management of hypothyroidism
Domenico Salvatore, Tommaso Porcelli, Matthew D Ettleson, et al.
Frontiers in Endocrinology
|
June 6, 2018
Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report
Tommaso Porcelli, Francesca Sessa, Angela Caputo, et al.
Endocrine-Related Cancer
|
March 2, 2023
Deiodinases in thyroid tumorigenesis
Maria Angela De Stefano, Tommaso Porcelli, Martin Schlumberger, et al.
Future Oncology (London, England)
|
August 15, 2019
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib
Tommaso Porcelli, Francesca Sessa, Carla Gambale, et al.
The Lancet. Diabetes & Endocrinology
|
July 17, 2025
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism
Tommaso Porcelli, Maria Angela De Stefano, Cristina Luongo, et al.
Metabolites
|
November 25, 2021
Thyroid Hormone Action in Muscle Atrophy
Maria Angela De Stefano, Raffaele Ambrosio, Tommaso Porcelli, et al.
Endocrine-Related Cancer
|
May 1, 2025
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, et al.
Endocrine-Related Cancer
|
March 6, 2023
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence
Maria Angela De Stefano, Tommaso Porcelli, Raffaele Ambrosio, et al.
Journal of Occupational and Environmental Medicine
|
June 22, 2022
The Impact of Thyroid Diseases on Patients' Work Functioning: A Pilot Study
Ilaria Vetrani, Veruscka Leso, Luca Fontana, et al.
Page
of 4